Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schulman

Showing results (11-20 of 5,685) with videos related to

Pageof 569
Sort By:
Journal of Perinatology : Official Journal of the California Perinatal Association|November 16, 2017
Systematic reviews and meta-analysis: why might more clinical trials yield no greater precision?Joseph Schulman
Prehospital Emergency Care|June 28, 2006
HIPAA privacy and security implications for field triageRoslyne Schulman
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 3, 2007
PSA: an updateClaude Schulman
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
NICU Notes: A Palm OS and Windows database software product and process to facilitate patient care in the newborn intensive care unitJoseph Schulman
Seminars in Thrombosis and Hemostasis|January 20, 2004
Why is factor Xa not a better target than factor IIa for therapeutic inhibition of coagulation?Sam Schulman
Pathophysiology of Haemostasis and Thrombosis|April 7, 2005
The role of ximelagatran in the treatment of venous thromboembolismSam Schulman
Revue Medicale De Bruxelles|October 19, 1999
[Benign hypertrophy of the prostate: which treatment, for whom?]C Schulman
Wiener Medizinische Wochenschrift (1946)|June 23, 1999
The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study GroupS Schulman
Haemostasis|January 12, 2000
For how long should the treatment with vitamin K antagonists be maintained?S Schulman
Leadership in Health Services = Leadership Dans Les Services De Sante|April 8, 1994
Professional advisory committee: a new initiative in governanceB Schulman
Pageof 569

Showing results (11-20 of 5,685) with videos related to

Sort By:
Pageof 569
Journal of Perinatology : Official Journal of the California Perinatal Association|November 16, 2017
Systematic reviews and meta-analysis: why might more clinical trials yield no greater precision?Joseph Schulman
Prehospital Emergency Care|June 28, 2006
HIPAA privacy and security implications for field triageRoslyne Schulman
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 3, 2007
PSA: an updateClaude Schulman
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
NICU Notes: A Palm OS and Windows database software product and process to facilitate patient care in the newborn intensive care unitJoseph Schulman
Seminars in Thrombosis and Hemostasis|January 20, 2004
Why is factor Xa not a better target than factor IIa for therapeutic inhibition of coagulation?Sam Schulman
Pathophysiology of Haemostasis and Thrombosis|April 7, 2005
The role of ximelagatran in the treatment of venous thromboembolismSam Schulman
Revue Medicale De Bruxelles|October 19, 1999
[Benign hypertrophy of the prostate: which treatment, for whom?]C Schulman
Wiener Medizinische Wochenschrift (1946)|June 23, 1999
The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study GroupS Schulman
Haemostasis|January 12, 2000
For how long should the treatment with vitamin K antagonists be maintained?S Schulman
Leadership in Health Services = Leadership Dans Les Services De Sante|April 8, 1994
Professional advisory committee: a new initiative in governanceB Schulman
Pageof 569